Clinical trial
A Multicenter, Randomized, Parallel, Controlled, Prospective, Open-label Study of the Efficacy and Safety of Longidaze Lyophilisate for Solution for Injections and Rectal Suppositories 3,000 IU in the Combined Treatment of Patients With Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
NCT06568718 is registered in ClinicalTrials.gov with NPO Petrovax as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized, Parallel, Controlled, Prospective, Open-label Study of the Efficacy and Safety of Longidaze Lyophilisate for Solution for Injections and Rectal Suppositories 3,000 IU in the Combined Treatment of Patients With Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
- Lead sponsor
- NPO Petrovax
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 20, 2023
- Completion date
- February 9, 2024
- Enrollment
- 229 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.